Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse
Other stock markets
 21:00:02 26/04/2024 BST 		5-day change 1st Jan Change
733.5 USD +1.19% Intraday chart for Eli Lilly and Company +0.99% +25.83%
04-25 Scholz pledges further support for the pharmaceutical industry DP
04-25 Scholz promises support for pharma sector in Germany as Merck invests RE

Chart calendar Eli Lilly and Company

833.4ps3vZoyEIKA724VaDrqOWZkS2ZY5E4zsSi7dd81AMU.kO5O3NBbaNbBpFtePHCDcyUAHTZuswpL_h-MM7FGQYOw2n7Z_AZc5fm1BQ~42cd8c60da6b547da5baca7e121befc4

Upcoming events on Eli Lilly and Company

30/04/2024 11:25 Q1 2024 Earnings Release
30/04/2024 15:00 Q1 2024 Earnings Call
06/05/2024 13:30 Annual General Meeting
21/06/2024 20:45 American Diabetes Association Scientific Meeting
08/08/2024 11:25 Q2 2024 Earnings Release
08/08/2024 15:00 Q2 2024 Earnings Call
30/10/2024 10:25 Q3 2024 Earnings Release
30/10/2024 14:00 Q3 2024 Earnings Call
29/01/2025 Q4 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)
04/08/2025 Q2 2025 Earnings Release (Projected)
03/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

08/04/2024 21:30 American Association for Cancer Research Meeting - Abstract Number: 3230
08/04/2024 21:30 American Association for Cancer Research Meeting - Abstract Number: 3316
08/04/2024 17:00 American Association for Cancer Research Meeting - Abstract Number: 1872
09/03/2024 American Academy of Dermatology Meeting
06/03/2024 14:10 TD Cowen Health Care Conference - Fireside Chat
13/02/2024 Ex-dividend day
06/02/2024 15:00 Q4 2023 Earnings Call
06/02/2024 11:45 Q4 2023 Earnings Release
09/01/2024 22:15 JPMorgan Healthcare Conference
12/12/2023 02:00 American Society of Hematology Meeting - Abstract No:5152
12/12/2023 01:00 American Society of Hematology Meeting - Abstract No:981
11/12/2023 02:00 American Society of Hematology Meeting - Abstract No:3269
11/12/2023 02:00 American Society of Hematology Meeting - Abstract No:3626
11/12/2023 02:00 American Society of Hematology Meeting - Abstract No:3026
10/12/2023 01:30 American Society of Hematology Meeting - Abstract No:1660
10/12/2023 01:30 American Society of Hematology Meeting - Abstract No:1737
10/12/2023 00:15 American Society of Hematology Meeting - Abstract No:326
09/12/2023 American Society of Hematology Meeting - Abstract No:325
08/12/2023 15:35 San Antonio Breast Cancer Symposium - Abstract #: 1569529
07/12/2023 12:12 San Antonio Breast Cancer Symposium - Abstract #: 1545518

Past dividends on Eli Lilly and Company

13/02/2024 Quarterly 1.3 USD
13/11/2023 Quarterly 1.13 USD
13/08/2023 Quarterly 1.13 USD
11/05/2023 Quarterly 1.13 USD
13/02/2023 Quarterly 1.13 USD
13/11/2022 Quarterly 0.98 USD
11/08/2022 Quarterly 0.98 USD
12/05/2022 Quarterly 0.98 USD
13/02/2022 Quarterly 0.98 USD
11/11/2021 Quarterly 0.85 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		22 320
22 142
0.8%		24 540
24 394
0.6%		28 318
28 205
0.4%		28 541
28 641
-0.35%		34 124
33 585
1.6%
41 355

EBITDA
Million USD		Released
Forecast
Spread 		7 551
7 508
0.57%		8 589
8 676
-1.01%		10 005
9 767
2.43%		9 473
9 494
-0.23%		8 584
8 418
1.98%
14 911

EBIT
Million USD		Released
Forecast
Spread 		6 079
6 106
-0.44%		7 265
7 503
-3.17%		8 457
8 599
-1.65%		7 950
8 164
-2.62%		7 057
6 928
1.86%
13 419

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		5 266
8 975
-41.33%		7 230
7 041
2.68%		6 156
7 148
-13.88%		6 806
7 084
-3.93%		6 555
6 311
3.86%
12 689

Net income
Million USD		Released
Forecast
Spread 		8 318
8 090
2.83%		6 194
5 805
6.69%		5 582
6 019
-7.27%		6 245
6 102
2.35%		5 240
5 307
-1.26%
10 864

EPS
USD		Released
Forecast
Spread 		8,89
8,65
2.83%		6,79
6,36
6.69%		6,12
6,43
-4.75%		6,90
6,60
4.57%		5,80
6,04
-3.92%
12,1

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		8 000
7 887
1.43%		7 810
7 319
6.7%		6 488
6 854
-5.33%		6 942
6 901
0.58%		7 302
7 376
-1%		6 960
6 867
1.36%		8 312
7 590
9.51%		9 499
8 965
5.96%		9 353
8 971
4.27%
8 930


9 844


10 716


11 788


10 745

EBITDA
Million USD		Released
Forecast
Spread 		2 982
2 595
14.9%		3 046
2 717
12.12%		1 679
2 387
-29.67%		2 373
2 385
-0.5%		2 375
2 268
4.72%		1 982
2 148
-7.73%		2 618
2 416
8.39%		986
3 460
-71.49%		2 855
3 517
-18.81%
2 827


3 002


3 783


4 475




EBIT
Million USD		Released
Forecast
Spread 		2 536
2 648
-4.23%		2 610
2 336
11.74%		1 330
1 790
-25.7%		2 010
2 007
0.13%		2 000
1 953
2.41%		1 620
1 840
-11.95%		2 252
2 078
8.37%		575
921
-37.56%		2 468
2 448
0.79%
2 674


2 973


3 589


4 161




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread

















2 089
2 107
-0.86%		427
-399
207.07%		2 509
1 248
101.03%
2 455


2 629


3 314


3 961




Net income
Million USD		Released
Forecast
Spread 		1 726
1 760
-1.93%		1 903
1 711
11.22%		953
1 133
-15.93%		1 452
1 453
-0.09%		1 938
1 681
15.27%		1 345
1 544
-12.9%		1 763
1 660
6.22%		-57,4
-813
92.94%		2 190
1 811
20.89%
2 058


2 370


2 879


3 504




EPS
USD		Released
Forecast
Spread 		1,90





1,05
1,85
-43.24%		1,61
1,90
-15.26%		2,14
1,78
20.22%		1,49
2,04
-26.96%		1,95
1,81
7.73%		-0,06
-0,66
90.91%		2,42
2,26
7%
2,44


2,60


3,26


3,78




Announcement Date03/02/2228/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/24-----

Upcoming sector events for Eli Lilly and Company

28/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
28/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
28/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
28/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for Eli Lilly and Company

26/04/2024 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
26/04/2024 NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
26/04/2024 LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
26/04/2024 HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
26/04/2024 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
26/04/2024 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
26/04/2024 GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
26/04/2024 NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
26/04/2024 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
26/04/2024 ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. Calendar Eli Lilly and Company